MassMutual Private Wealth & Trust’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.44K Hold
410
﹤0.01% 1821
2026
Q1
$3.4K Hold
410
﹤0.01% 1816
2025
Q4
$5.07K Hold
410
﹤0.01% 1672
2025
Q3
$3.62K Hold
410
﹤0.01% 1798
2025
Q2
$2.62K Hold
410
﹤0.01% 1872
2025
Q1
$1.99K Hold
410
﹤0.01% 1917
2024
Q4
$3.92K Hold
410
﹤0.01% 1619
2024
Q3
$3.42K Hold
410
﹤0.01% 1491
2024
Q2
$2.8K Buy
+410
New +$1.76K ﹤0.01% 1521
2022
Q4
Sell
-15
Closed 1693
2022
Q3
$0 Hold
15
﹤0.01% 1662
2022
Q2
$0 Buy
+15
New +$512 ﹤0.01% 1566
2022
Q1
Sell
-56
Closed -$2K 1552
2021
Q4
$2K Buy
+56
New +$2.53K ﹤0.01% 1086

Other funds holding EBS

MassMutual Private Wealth & Trust's EBS Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Emergent Biosolutions (EBS) position steady in Q2 2026 at 410 shares worth $3.44K. The position accounts for ﹤0.01% of the portfolio, ranked #1821.

MassMutual Private Wealth & Trust first reported a position in EBS in Q4 2021 and has held it in 12 quarters since. The position peaked at $5.07K in Q4 2025. 20 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • MassMutual Private Wealth & Trust held 410 shares of Emergent Biosolutions worth $3.44K as of Q2 2026.
  • MassMutual Private Wealth & Trust left its Emergent Biosolutions share count unchanged in Q2 2026.
  • Emergent Biosolutions made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1821 holding.
  • MassMutual Private Wealth & Trust first reported a position in Emergent Biosolutions in Q4 2021 and has held it in 12 quarters since.
  • MassMutual Private Wealth & Trust's Emergent Biosolutions position peaked at $5.07K in Q4 2025.
  • 20 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.